Constraint-Induced Movement Therapy Plus Sensory Components After Stroke
This study is testing a treatment called Constraint-Induced Movement Therapy (CI Therapy) with added sensory components for people who have had a stroke (CVA) and still have weakness (paresis) in their arm. The goal is to see if this combined therapy can improve how well you use your affected arm, your arm's movement ability, and your sensory perception after a stroke. All participants will receive this therapy over 2 or 3 weeks. Researchers will measure arm use and ability using tests like the Motor Activity Log. You might be able to join if you are 18 to 89 years old, had a stroke at least 6 months ago, and can move your shoulder, elbow, wrist, or fingers to a certain degree. The study plans to enroll 15 participants, but its current status is unclear.
- Study design
- This is an interventional study, meaning all participants will receive the treatment. It aims to enroll 15 people.
- What's involved
- You would receive Constraint-Induced Movement Therapy plus sensory components for 2 to 3 weeks. Your arm use and movement will be measured after treatment.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your arm use will be measured again 3 months after the end of treatment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Constraint-Induced Movement Therapy Plus Sensory Components After Stroke
At a glance
Conditions
NCT05515237
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
University of Alabama at Birmingham
Birmingham, Alabamastudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- David Morris, PhD · STUDY_CHAIR · University of Alabama at Birmingham
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Motor Activity LogAt post treatment after 2 weeks of intervention for participants with mild-moderate UE impairment
The Motor Activity Log is a semi-structured interview that assesses the amount of use and the quality of use of the more-affected UE in 30 activities of daily living. This test is used to determine the change how much and how well the participant uses the more-affected arm and hand outside of the laboratory setting and in the life situation. It is administered before and after treatment. The score is derived from two scales that are each 0-5 and reported as a mean for the Amount of Use (AOU) and mean for the Quality of Use (QOM).
- Motor Activity LogAt 3 month follow up after the end of treatment
The Motor Activity Log is a semi-structured interview that assesses the amount of use and the quality of use of the more-affected UE in 30 activities of daily living. This test is used to determine the change how much and how well the participant uses the more-affected arm and hand outside of the laboratory setting and in the life situation. It is administered before and after treatment. The score is derived from two scales that are each 0-5 and reported as a mean for the Amount of Use (AOU) and mean for the Quality of Use (QOM).
- G4/5 Motor Activity LogAt post treatment after 3 weeks of intervention for participants with severe UE impairment
The G4/5 Motor Activity Log is a semi-structured interview that assesses the amount of use and the quality of use of the more-affected UE in 30 activities of daily living. This test is used to determine the change how much and how well the participant uses the more-affected arm and hand outside of the laboratory setting and in the life situation. It is administered before and after treatment. The score is derived from two scales that are each 0-5 and reported as a mean for the Amount of Use (AOU) and mean for the Quality of Use (QOM).
- G4/5 Motor Activity Log (G4/5 MAL)At 3 month follow up after the end of treatment
The G4/5 Motor Activity Log is a semi-structured interview that assesses the amount of use and the quality of use of the more-affected UE in 30 activities of daily living. This test is used to determine the change how much and how well the participant uses the more-affected arm and hand outside of the laboratory setting and in the life situation. It is administered before and after treatment. The score is derived from two scales that are each 0-5 and reported as a mean for the Amount of Use (AOU) and mean for the Quality of Use (QOM).
- Wolf Motor Function Test(WMFT)At post treatment after the 2 weeks of intervention for mild to moderately impaired participants
The WMFT is a standardized performance capacity test that measures the motor ability of the upper extremities of a participant. The performance time is measured using a stopwatch and a functional ability (quality) score is provided for each item tested. This test is administered before treatment and after treatment. The quality of movement is rated by the therapist on a scale from 0-5 with 0 representing the participant's inability to perform the task, and 5 representing normal movement or as good as before the stroke, such that a higher functional ability score is better. A lower performance time represents a better performance.
- Grade 5 Graded Wolf Motor Function Test (G5 GWMFT)At post treatment after the 3 weeks of intervention for severely impaired participants
The G5 Graded WMFT is a standardized motor performance test that measures the motor ability of the upper extremities of a participant. The performance time is measured using a stopwatch and the functional ability (quality) score is provided for each item tested. It is administered before treatment and after treatment. The quality of movement is rated by the therapist on a scale from 0-7 with 0 representing the participant's inability to perform the task, and 7 representing normal movement or as good as before the stroke, such that a higher functional ability score is better. A lower performance time represents a better performance.
- Canadian Occupational Performance Measure (COPM)At post treatment after the 2-3 weeks of intervention, depending on the severity of the impairment.
The COPM is a semi-structured interview in which the participant is asked to rate their desired occupational performance areas in activities of daily living and instrumental activities of daily living. The COPM is used to show changes in the performance and satisfaction in desired areas of occupational performance. There are three scales used in the COPM administration one for importance, performance, and satisfaction. The scales range from 1-10 with the higher score indicating an improvement in the score.
- Canadian Occupational Performance Measure (COPM)At 3 month follow up after the end of treatment
The COPM is a semi-structured interview in which the participant is asked to rate their desired occupational performance areas in activities of daily living and instrumental activities of daily living. The COPM is used to show changes in the performance and satisfaction in desired areas of occupational performance. There are three scales used in the COPM administration one for importance, performance, and satisfaction. The scales range from 1-10 with the higher score indicating an improvement in the score.